Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Chesnara Plc LSE:CSN London Ordinary Share GB00B00FPT80 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -4.00p -1.06% 372.50p 370.50p 372.00p 376.50p 370.00p 373.00p 22,362 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Life Insurance 274.9 27.0 16.1 23.1 558.23

Chesnara Share Discussion Threads

Showing 1676 to 1699 of 1700 messages
Chat Pages: 68  67  66  65  64  63  62  61  60  59  58  57  Older
DateSubjectAuthorDiscuss
11/4/2019
09:14
Ex-Div today.
al101uk
02/4/2019
13:49
Chesnara PLC cashed up and looking for more deals - HTTPS://youtu.be/ePJJFaAd-t8 Chesnara PLC's (LON:CSN) chief executive John Deane talks Proactive's Andrew Scott through their 2018 results. Economic value fell 13% to £626mln due to falling bond and equity prices and a stronger pound with an economic loss for the year of £60.9mln. The dividend for the year rose 3% to 20.67p and its solvency ratio strengthened to 158% of its regulatory requirement following the cash generation of £47.8mln. Deane says they're now in a strong position to make more acquisitions.
speedsgh
30/3/2019
06:17
IC comment: Chesnara (CSN) reported a two-thirds rise in cash generation for 2018, which supported a 3 per cent rise in the dividend. However, cash generation was impacted slightly by a fall in the value of bonds within the Scildon portfolio, partly offset by the release of capital from UK with-profits funds. However, a rise in the Solvency II ratios for Movestic and Waard meant the group’s Solvency II ratio rose to 158 per cent from 146 per cent the prior year. Buy.
jonwig
29/3/2019
09:59
If everyone had a good idea of when the ex-div date was it would avoid that shock horror of suddenly seeing the share price drop for no apparent reason. As happens to me once in a while!
eggbaconandbubble
29/3/2019
08:26
Yes you make a good point I wonder why they do it?
luderitz
29/3/2019
07:55
Many company reports bury dividend info, especially the dates, deep down in the small print. Likewise on their websites, the dates are often not included in the financial calendar, which would seem the obvious logical place, but buried away elsewhere. Should be given much more prominence IMHO.
thamestrader
29/3/2019
07:25
Here are the FY results: https://www.investegate.co.uk/chesnara-plc--csn-/rns/final-results/201903290700033950U/ Positive: solvency improved from 146% to 158% (that's the key number for me). Negative: ECV fell from £723m to £626m... Economic Value in the period has been more affected by economic conditions with total value falling by £97.0m. The majority of the loss is directly due to economic conditions. Operating losses of £22.8m including the impact of the strengthening of Scildon mortality assumptions, have also contributed to the reduction. Foreign exchange losses of £5.8m have emerged in the period, largely as a result of a weakening of Swedish krona. These factors, coupled with the payment of £30.4m of dividends have resulted in a 13.4% reduction in EcV since the start of the year. Scildon (was L&G Netherlands) might be a bit of a problem for them - seems to be mainly responsible for ECV fall. Had to read almost to the end before I found the dividend dates: 13.46p, ex 11/04, pay 24/05. Overall, market reaction might be a bit cautious.
jonwig
22/3/2019
16:32
Euro and Swedish krone.
jonwig
22/3/2019
14:40
How do currency rates affect this share?
zeppo
22/3/2019
10:58
Results due. Now looks like the only thing of interest to be happening on 29th March!
eggbaconandbubble
19/3/2019
10:17
Nice to see a bit of positivity returning to the share price prior to results a week on Friday (29 Mar). Now back above 200 SMA.
speedsgh
04/3/2019
15:45
HTTP://www.chesnara.co.uk/investor-relations/financial-calendar 29 Mar 2019 - Results Announcement 11 Apr 2019 - Final Ex Dividend Date 24 May 2019 - Final Dividend Payment
speedsgh
31/12/2018
12:39
EI - yes, financials do underpreform, so it's important to distinguish which companies might be genuinely distressed rather than just going with the market flow. As it happened, the insurance sector weathered the GFC pretty well: wasn't AIG the only major casualty?
jonwig
31/12/2018
07:54
Not sure there is anything mystifying. CSN tends to underperform during market corrections, as in 2011 and 2016 post referendum. Many 'financials' do the same.
essentialinvestor
31/12/2018
07:45
Thanks for your input jonwig. I am not an “insurance expert” either and use CSN as a bond proxy (and cash bank alternative) so it always concerns me when the share price takes these “mystifying221; diversions! I think you are correct that, in the longer term, the solvency ratio is the best test of the value and stability of the share price However, other players in the market appear, every now and then, to drop the share price in the short term. Whether this is based on fundamentals, share liquidity or other reasons I know not but I expected, and expect, CSN to be more stable through market cycles. Maybe there is more irrationality in the market than I, as a mere amateur, can rationalise? ;-) Best wishes all for a prosperous 2019!
sogoesit
27/12/2018
17:26
The share price here has often shown mystifying behaviour, so the question is how to value the company. Insurance accounting is still pretty opaque for me, but maybe a key number is "solvency ratio". Solvency ratio was 157% at 30/06, meaning (roughly) that it would fall to the critical 100% if supporting assets fell by 36%. Since these will be bonds rather more than equities, that's pretty unlikely. (Isn't it?) The SR has varied between 143% and 148% since end-2015. At 30/06/15 it was 271%, but that predates Solvency 2 so isn't really comparable. Another factor is FX gains/losses. Actually I don't think these matter, as SKR, say, is kept to service the Swedish arm, and changes only when account are drawn up in GBP. It's worth saying that CSN uses external fund managers (Schroders, I think), as does PHNX (SLA). They used to quote an embedded value, but that's stopped, and they now quote "Economic value" - EV per share at 30/06/18 was 467p, though this isn't a recognised measure. The company has net cash (ie. debt is irrelevant). So when FY results to 31/12 are published in March I'd be surprised if the SR fell by more that 10% (ie. to 141%), and I'd be comfortable with that.
jonwig
21/12/2018
16:43
360.5 paid for 73,000!
spittingbarrel
21/12/2018
16:42
nice reversal today
mister md
21/12/2018
10:14
Many thanks alter ego... my scrolling missed that! I shall revert to closer reading as the sensitivities, on page 126 of the 2017 Annual Report, surprised me. Gabster points to an opportunity on the yield and that's the reason I was taking a look again. CSN is about 7% of my portfolio. I consolidated in CSN after selling out of PHNX some time back. To do with the Italian Bonds (I assume) this comment is also made in the Overview/Scildon Section of the Half Year 2018 (page 9): "When assessed in terms of levels of cash generated in the period we have, with the exception of Scildon, delivered broadly in line with expectations. £16.1m of cash emerged from the UK division during the period which, together with £26.8m of previously constrained surplus released from the with-profits fund, resulted in total cash significantly in excess of recent dividend payments. Movestic has increased its level of surplus resulting in a further £7.3m of cash generation. Scildon has reported negative cash generation of £2.3m. This is primarily due to the impact of valuation pressures on its fixed interest investments. The result in the period does not in itself impact our view regarding the future cash generation of the business." PS: Anyway, Italian Bonds are now improving following the budget deal with their EU masters: htTps://www.bloomberg.com/quote/GBTPGR10:IND
sogoesit
21/12/2018
09:59
Sogoesit, "All divisions have made positive contributions, with the exception of Scildon, where operational gains were offset by the impact of losses on Italian bond holdings." from latest half year report
alter ego
21/12/2018
09:48
Even if asset values are affected rising rates should not affect cash flow which is used to pay the dividend. As long as that is safe any capital appreciation swings will be rectified long term and dividend increased. Now is a good time to take advantage of juicy yields.
gabsterx
21/12/2018
09:47
@ Sogoesit - I've been meaning to look more closely again at CSN (described by the CEO as "hopefully the most boring company in your portfolio"). maybe before the silly season gets under way.
jonwig
21/12/2018
09:42
Hmmm... not convinced. Surprisingly, they mention a (substantial) negative sensitivity to rising market interest rates. So I am wrong for my second point which was based on a changing underlying discount factor. Maybe that explains it. I don't see any mention of Italian Bonds. Happy to be corrected, 'tho. I will have to keep digging given my previous assumptions.
sogoesit
20/12/2018
07:58
Spot on jonwig
solarno lopez
Chat Pages: 68  67  66  65  64  63  62  61  60  59  58  57  Older
Your Recent History
LSE
CSN
Chesnara
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190521 01:26:51